ALNY Alnylam Pharmaceuticals Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
19:52
Jul 09
Jul 09
Author mentions covering a position in ALNY early, no current directional view or catalyst.
LOW
12:13
Jul 09
Jul 09
Premarket movers report shows mixed Mag 7 stocks.
Premarket movers report shows mixed Mag 7 stocks, with notable gains for CECO on JPMorgan initiation, ALNY and BBIO on rival drug trial failure, and SMPL on earnings beat, while IBM, IONS, LEVI, MAT, and CRM decline on various negative catalysts.
12:21
Jun 15
Jun 15
Watch these companies as top contenders for next quarter’s S&P 500 addition if profitability.
Watch these companies as top contenders for next quarter’s S&P 500 addition if profitability improves.
MED
21:30
Feb 10
Feb 10
Gilead's BD focus could target RNAi or other modalities where Alnylam is a leader, though no specific deal mentioned.
LOW
About ALNY Analyst Coverage
Buzzberg tracks ALNY (Alnylam Pharmaceuticals) across 4 sources. 0 bullish vs 0 bearish calls from 4 analysts. Sentiment: evenly split. 4 total trade ideas tracked. Latest voices: Martin Shkreli, zerohedge, TheValueist.